Search

Author/Creator Nadal, E

1. 1407PDerived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients. (23rd October 2018)

Authors:
Mezquita, L; Arbour, K; Auclin, E; Saravia, D; Rizvi, H; Hendriks, L; Planchard, D; Park, W; Nadal, E; Ruffinelli Rodriguez, J C; Ponce, S; Audigier-Valette, C; Marilniello, A P; Zalcman, G; Majem, M; Schiavone, G; Dingemans, A-M C; Lopes, G; Hellmann, M D; Besse, B
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 17P Association of lung immune prognostic index (LIPI) with survival of first line immune checkpoint inhibitors single agent or in combination with chemotherapy in untreated advanced NSCLC patients. (15th December 2019)

Authors:
Blanc-Durand, F; Auclin, E; Planchard, D; Aix, S Ponce; Hendriks, L; Sullivan, I G; Saravia, D; Routy, B; Castro, R Lopez; Pilotto, S; Aboubakar, F; Kassouf, E; Rodriguez, A; Martin, A Amores; Bluthgen, M V; Duchemann, B; Caramella, C; Nadal, E; Besse, B; Mezquita, L
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases. (19th September 2018)

Authors:
Alemany, M; Domènech, M; Vilariño, N; Jové, M; Brao, I; Arellano, M; Lucas, A; Navarro, A; Palmero, R; Simó, M; Velasco, R; Nadal, E; Bruna, J
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 3
Page Start:
iii307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. P05.21 T1-flair to T1-gadolinium MRI ratio as a predictive value of treatment response in non-small-cell lung cancer (NSCLC) patients affected by multiple brain metastases. (19th September 2018)

Authors:
Alemany, M; Domènech, M; Vilariño, N; Jové, M; Brao, I; Arellano, M; Lucas, A; Navarro, A; Palmero, R; Simó, M; Velasco, R; Nadal, E; Bruna, J
Journal:
Neuro-oncology
Issue:
Volume 20(2018)Supplement 3
Page Start:
iii307
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. P16.01.A Factors predicting cognitive impairment after intrathecal methotrexate treatment in patients with non-small cell lung cancer and leptomeningeal disease. (5th September 2022)

Authors:
Vilariño, N; Esparragosa, I; Marín, J; Alemany, M; Velasco, R; Jové, M; Brenes, J; Palmero, R; Brao, I; Arellano, M; Sala, R; Bruna, J; Nadal, E; Simó, M
Journal:
Neuro-oncology
Issue:
Volume 24(2022)Supplement 2
Page Start:
ii87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in patients with untreated, EGFR-mutated, metastatic non-small cell lung cancer: Europe/United States subset analysis. (2021)

Authors:
Ponce Aix, S; Novello, S; Garon, EB; Nakagawa, K; Nadal, E; Moro-Sibilot, D; Alonso Garcia, M; Fabre, E; Frimodt-Moller, B; Zimmermann, AH; Visseren-Grul, CM; Reck, M
Journal:
Cancer treatment and research communications
Issue:
Number 27(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗